Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that effective as of September 11, 2024, its board of directors authorized ...

Inc. Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary ...

Q4 2024 Earnings Call Transcript August 27, 2024 Electromed, Inc. beats earnings expectations. Reported EPS is $0.2, ...

NEW PRAGUE, Minn., August 27, 2024 -- ( BUSINESS WIRE )--Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results ...

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. It offers smartvest, and airways clearance system to patients with compromised pulmonary function.

Earlier today, Electromed Incorporated released financial results for the fourth fiscal quarter of 2024, the quarter ended June 30, 2024. The release is currently available on the Company's website at ...

Inc. Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary ...